Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial

被引：0
|
作者：
Nils Venhoff
Wolfgang A. Schmidt
Peter Lamprecht
Hans-Peter Tony
Christine App
Christian Sieder
Carolin Legeler
Claudia Jentzsch
Jens Thiel
机构：
[1] Klinik für Rheumatologie und Klinische Immunologie,Department Innere Medizin
[2] Vaskulitiszentrum Freiburg,Department of Immunology, Hepatology & Dermatology
[3] Universitätsklinikum Freiburg,undefined
[4] Immanuel Krankenhaus Berlin,undefined
[5] Klinik für Innere Medizin,undefined
[6] Abteilung Rheumatologie und Klinische Immunologie in Berlin-Buch,undefined
[7] Universität zu Lübeck,undefined
[8] Klinik für Rheumatologie und klinische Immunologie,undefined
[9] Medizinische Klinik II,undefined
[10] Universitätsklinik,undefined
[11] Rheumatology/Immunology,undefined
[12] Novartis Pharma GmbH,undefined
[13] Novartis Pharma AG,undefined
来源：
Trials | / 22卷
关键词：
Giant cell arteritis; Secukinumab; Phase II trial; Placebo; Double-blind;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Efficacy and safety of secukinumab in patients with giant cell arteritis: study protocol for a randomized, parallel group, double-blind, placebo-controlled phase II trial
    Venhoff, Nils
    Schmidt, Wolfgang A.
    Lamprecht, Peter
    Tony, Hans-Peter
    App, Christine
    Sieder, Christian
    Legeler, Carolin
    Jentzsch, Claudia
    Thiel, Jens
    [J]. TRIALS, 2021, 22 (01)
  • [2] Secukinumab in Giant Cell Arteritis: A Randomized, Parallel-group, Double-blind, Placebo-controlled, Multicenter Phase 2 Trial
    Venhoff, Nils
    Schmidt, Wolfgang
    Bergner, Raoul
    Rech, Juergen
    Unger, Leonore
    Tony, Hans-Peter
    Mendelson, Meryl
    Sieder, Christian
    Maricos, Meron
    Thiel, Jens
    [J]. ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 4130 - 4133
  • [3] SECUKINUMAB IN GIANT CELL ARTERITIS: THE RANDOMISED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE PHASE 2 TITAIN TRIAL
    Venhoff, N.
    Schmidt, W. A.
    Bergner, R.
    Rech, J.
    Unger, L.
    Tony, H. P.
    Mendelson, M.
    Sieder, C.
    Maricos, M.
    Thiel, J.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 121 - 122
  • [4] A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis
    Wolfgang A. Schmidt
    Bhaskar Dasgupta
    Jennifer Sloane
    Angeliki Giannelou
    Yuqing Xu
    Sebastian H. Unizony
    Sarah L. Mackie
    Miguel A. Gonzalez-Gay
    Robert Spiera
    Kenneth J. Warrington
    Peter M. Villiger
    Michael C. Nivens
    Bolanle Akinlade
    Yong Lin
    Frank Buttgereit
    John H. Stone
    [J]. Arthritis Research & Therapy, 25
  • [5] A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis
    Schmidt, Wolfgang A.
    Dasgupta, Bhaskar
    Sloane, Jennifer
    Giannelou, Angeliki
    Xu, Yuqing
    Unizony, Sebastian H.
    Mackie, Sarah L.
    Gonzalez-Gay, Miguel A.
    Spiera, Robert
    Warrington, Kenneth J.
    Villiger, Peter M.
    Nivens, Michael C.
    Akinlade, Bolanle
    Lin, Yong
    Buttgereit, Frank
    Stone, John H.
    [J]. ARTHRITIS RESEARCH & THERAPY, 2023, 25 (01)
  • [6] Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo- controlled, phase 2 trial
    Venhoff, Nils
    Schmidt, Wolfgang A.
    Bergner, Raoul
    Rech, Juergen
    Unger, Leonore
    Tony, Hans -Peter
    Finzel, Stephanie
    Andreica, Ioana
    Kofler, David M.
    Weiner, Stefan M.
    Lamprecht, Peter
    Schulze-Koops, Hendrik
    App, Christine
    Pournara, Effie
    Mendelson, Meryl H.
    Sieder, Christian
    Maricos, Meron
    Thiel, Jens
    [J]. LANCET RHEUMATOLOGY, 2023, 5 (06): : e341 - e350
  • [7] Efficacy and safety of mavrilimumab in giant cell arteritis: a phase 2, randomised, double-blind, placebo-controlled trial
    Cid, Maria C.
    Unizony, Sebastian H.
    Blockmans, Daniel
    Brouwer, Elisabeth
    Dagna, Lorenzo
    Dasgupta, Bhaskar
    Hellmich, Bernhard
    Molloy, Eamonn
    Salvarani, Carlo
    Trapnell, Bruce C.
    Warrington, Kenneth J.
    Wicks, Ian
    Samant, Manoj
    Zhou, Teresa
    Pupim, Lara
    Paolini, John F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (05) : 653 - 661
  • [8] A MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF SIRUKUMAB IN THE TREATMENT OF PATIENTS WITH GIANT CELL ARTERITIS
    Schmidt, Wolfgang
    Dasgupta, Bhaskar
    Luqmani, Raashid
    Unizony, Sebastian
    Lai, Zhihong
    Kurrasch, Regina
    Lazic, Ivana
    Brown, Kurt
    Rao, Ravi
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 827 - 827
  • [9] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF GEVOKIZUMAB IN THE TREATMENT OF GIANT CELL ARTERITIS
    Dasgupta, Bhaskar
    [J]. RHEUMATOLOGY, 2014, 53 : 7 - 7
  • [10] The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis—study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study
    Lena Kreis
    Christian Dejaco
    Wolfgang Andreas Schmidt
    Robert Németh
    Nils Venhoff
    Valentin Sebastian Schäfer
    [J]. Trials, 25
12345